Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

OSSUY

Embla Medical hf.

USD

Set alert

Price alert · OSSUY

All alert types
4.23 USD 0.00 0.00%
As of Oct 29, 2026
4.23 Day range 4.23
3.67 52-week range 5.61
YTD
-21.52%
1 year
+5.75%
Open
4.23
Prev close
4.23
Mkt cap
1.80B
Vol
1.00K
Avg vol
15
EPS
0.22
P/E
19.23
More statistics
Low
4.23
High
4.23

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for OSSUY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.13 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 26.9×
FY 2016: 38.8×FY 2017: 35.8×FY 2018: 24.5×FY 2019: 43.8×FY 2020: 81.0×FY 2021: 43.2×FY 2022: 36.3×FY 2023: 28.9×FY 2024: 25.3×FY 2025: 26.9×
FY 2016 5y median 28.9× FY 2025
P/S 2.5×
FY 2016: 3.9×FY 2017: 3.5×FY 2018: 3.2×FY 2019: 4.3×FY 2020: 0.8×FY 2021: 3.8×FY 2022: 2.1×FY 2023: 2.2×FY 2024: 2.0×FY 2025: 2.5×
FY 2016 5y median 2.2× FY 2025
P/B 2.6×
FY 2016: 4.3×FY 2017: 4.0×FY 2018: 3.7×FY 2019: 5.3×FY 2020: 0.9×FY 2021: 4.4×FY 2022: 2.4×FY 2023: 2.4×FY 2024: 2.2×FY 2025: 2.6×
FY 2016 5y median 2.4× FY 2025
P/FCF 20.0×
FY 2016: 44.5×FY 2017: 33.4×FY 2018: 37.5×FY 2019: 39.2×FY 2020: 6.4×FY 2021: 32.6×FY 2022: 34.2×FY 2023: 26.0×FY 2024: 19.4×FY 2025: 20.0×
FY 2016 5y median 26.0× FY 2025
EV/EBITDA 15.8×
FY 2016: 22.8×FY 2017: 22.3×FY 2018: 17.6×FY 2019: 22.7×FY 2020: 12.3×FY 2021: 20.6×FY 2022: 16.3×FY 2023: 14.6×FY 2024: 12.8×FY 2025: 15.8×
FY 2016 5y median 15.8× FY 2025
EV/Sales 3.1×
FY 2016: 4.2×FY 2017: 3.7×FY 2018: 3.5×FY 2019: 4.8×FY 2020: 1.4×FY 2021: 4.3×FY 2022: 2.7×FY 2023: 2.7×FY 2024: 2.5×FY 2025: 3.1×
FY 2016 5y median 2.7× FY 2025
FCF Yield 5.0%
FY 2016: 2.2%FY 2017: 3.0%FY 2018: 2.7%FY 2019: 2.6%FY 2020: 15.7%FY 2021: 3.1%FY 2022: 2.9%FY 2023: 3.8%FY 2024: 5.2%FY 2025: 5.0%
FY 2016 5y median 3.8% FY 2025

Profitability

Gross Margin 58.2%
FY 2016: 60.7%FY 2017: 60.1%FY 2018: 60.8%FY 2019: 60.0%FY 2020: 57.3%FY 2021: 58.6%FY 2022: 56.8%FY 2023: 57.8%FY 2024: 58.5%FY 2025: 58.2%
FY 2016 5y median 58.2% FY 2025
Operating Margin 13.4%
FY 2016: 14.7%FY 2017: 14.1%FY 2018: 13.5%FY 2019: 15.4%FY 2020: 8.6%FY 2021: 13.3%FY 2022: 11.8%FY 2023: 11.1%FY 2024: 13.2%FY 2025: 13.4%
FY 2016 5y median 13.2% FY 2025
Net Margin 9.0%
FY 2016: 9.8%FY 2017: 10.1%FY 2018: 13.0%FY 2019: 9.6%FY 2020: 1.0%FY 2021: 8.9%FY 2022: 5.9%FY 2023: 7.4%FY 2024: 8.0%FY 2025: 9.0%
FY 2016 5y median 8.0% FY 2025
ROE 9.4%
FY 2016: 10.8%FY 2017: 11.5%FY 2018: 14.9%FY 2019: 11.7%FY 2020: 1.1%FY 2021: 10.3%FY 2022: 6.7%FY 2023: 8.3%FY 2024: 8.8%FY 2025: 9.4%
FY 2016 5y median 8.8% FY 2025
ROIC 6.3%
FY 2016: 8.6%FY 2017: 9.7%FY 2018: 8.4%FY 2019: 8.3%FY 2020: 3.0%FY 2021: 6.4%FY 2022: 5.6%FY 2023: 5.5%FY 2024: 6.2%FY 2025: 6.3%
FY 2016 5y median 6.2% FY 2025
ROA 4.8%
FY 2016: 6.8%FY 2017: 7.2%FY 2018: 8.7%FY 2019: 6.1%FY 2020: 0.5%FY 2021: 5.1%FY 2022: 3.2%FY 2023: 4.2%FY 2024: 4.4%FY 2025: 4.8%
FY 2016 5y median 4.4% FY 2025

Growth (YoY)

Revenue 9.0%
FY 2016: 7.6%FY 2017: 9.3%FY 2018: 7.9%FY 2019: 12.0%FY 2020: -8.3%FY 2021: 14.2%FY 2022: -0.0%FY 2023: 9.3%FY 2024: 8.8%FY 2025: 9.0%
FY 2016 FY 2025
Operating Income 11.0%
FY 2016: -1.0%FY 2017: 5.1%FY 2018: 3.3%FY 2019: 27.5%FY 2020: -48.9%FY 2021: 76.9%FY 2022: -11.0%FY 2023: 2.7%FY 2024: 28.9%FY 2025: 11.0%
FY 2016 FY 2025
EPS (diluted) 25.0%
FY 2016: 9.1%FY 2017: 8.3%FY 2018: 46.2%FY 2019: -15.8%FY 2020: -90.8%FY 2021: 920.4%FY 2022: -33.3%FY 2023: 40.0%FY 2024: 14.3%FY 2025: 25.0%
FY 2016 FY 2025
Free Cash Flow 29.2%
FY 2016: -1.7%FY 2017: 30.7%FY 2018: -12.1%FY 2019: 43.4%FY 2020: 4.0%FY 2021: 6.5%FY 2022: -47.1%FY 2023: 47.6%FY 2024: 36.1%FY 2025: 29.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.5×
FY 2016: 1.8×FY 2017: 1.8×FY 2018: 2.3×FY 2019: 2.2×FY 2020: 2.2×FY 2021: 1.7×FY 2022: 1.5×FY 2023: 1.9×FY 2024: 1.9×FY 2025: 1.5×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 0.9×
FY 2016: 1.2×FY 2017: 1.2×FY 2018: 1.5×FY 2019: 1.4×FY 2020: 1.6×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 0.9×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.8×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.6×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 3.2×
FY 2016: 1.3×FY 2017: 1.3×FY 2018: 1.5×FY 2019: 2.1×FY 2020: 5.3×FY 2021: 2.4×FY 2022: 3.4×FY 2023: 2.8×FY 2024: 2.5×FY 2025: 3.2×
FY 2016 5y median 2.8× FY 2025
Interest Coverage 5.9×
FY 2016: 20.2×FY 2017: 20.1×FY 2018: 16.9×FY 2019: 10.4×FY 2020: 5.0×FY 2021: 7.5×FY 2022: 6.6×FY 2023: 4.2×FY 2024: 4.6×FY 2025: 5.9×
FY 2016 5y median 5.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.4%FY 2017: 0.4%FY 2018: 0.5%FY 2019: 0.3%FY 2020: 1.9%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 15.5%FY 2017: 12.9%FY 2018: 11.6%FY 2019: 13.7%FY 2020: 149.7%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31